133 related articles for article (PubMed ID: 27256571)
1. Anti-JAM-C therapy eliminates tumor engraftment in a xenograft model of mantle cell lymphoma.
Doñate C; Vijaya Kumar A; Imhof BA; Matthes T
J Leukoc Biol; 2016 Nov; 100(5):843-853. PubMed ID: 27256571
[TBL] [Abstract][Full Text] [Related]
2. Homing of human B cells to lymphoid organs and B-cell lymphoma engraftment are controlled by cell adhesion molecule JAM-C.
Doñate C; Ody C; McKee T; Ruault-Jungblut S; Fischer N; Ropraz P; Imhof BA; Matthes T
Cancer Res; 2013 Jan; 73(2):640-51. PubMed ID: 23221386
[TBL] [Abstract][Full Text] [Related]
3. A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.
Wang M; Zhang L; Han X; Yang J; Qian J; Hong S; Lin P; Shi Y; Romaguera J; Kwak LW; Yi Q
Clin Cancer Res; 2008 Apr; 14(7):2154-60. PubMed ID: 18381957
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance.
Kim A; Seong KM; Kang HJ; Park S; Lee SS
Oncotarget; 2015 Nov; 6(35):38225-38. PubMed ID: 26517678
[TBL] [Abstract][Full Text] [Related]
5. Anti-idiotype x anti-CD44 bispecific antibodies inhibit invasion of lymphoid organs by B cell lymphoma.
Avin E; Haimovich J; Hollander N
J Immunol; 2004 Oct; 173(7):4736-43. PubMed ID: 15383611
[TBL] [Abstract][Full Text] [Related]
6. JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide.
Xu PP; Sun YF; Fang Y; Song Q; Yan ZX; Chen Y; Jiang XF; Fei XC; Zhao Y; Leboeuf C; Li B; Wang CF; Janin A; Wang L; Zhao WL
Sci Rep; 2017 Aug; 7(1):7433. PubMed ID: 28785100
[TBL] [Abstract][Full Text] [Related]
7. Function of Jam-B/Jam-C interaction in homing and mobilization of human and mouse hematopoietic stem and progenitor cells.
Arcangeli ML; Bardin F; Frontera V; Bidaut G; Obrados E; Adams RH; Chabannon C; Aurrand-Lions M
Stem Cells; 2014 Apr; 32(4):1043-54. PubMed ID: 24357068
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell-based therapy for mantle cell lymphoma.
Munger CM; Vose JM; Joshi SS
Int J Oncol; 2006 Jun; 28(6):1337-43. PubMed ID: 16685434
[TBL] [Abstract][Full Text] [Related]
9. Junctional adhesion molecule C (JAM-C) distinguishes CD27+ germinal center B lymphocytes from non-germinal center cells and constitutes a new diagnostic tool for B-cell malignancies.
Ody C; Jungblut-Ruault S; Cossali D; Barnet M; Aurrand-Lions M; Imhof BA; Matthes T
Leukemia; 2007 Jun; 21(6):1285-93. PubMed ID: 17429428
[TBL] [Abstract][Full Text] [Related]
10. Essential role of junctional adhesion molecule-1 in basic fibroblast growth factor-induced endothelial cell migration.
Naik MU; Vuppalanchi D; Naik UP
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2165-71. PubMed ID: 12958043
[TBL] [Abstract][Full Text] [Related]
11. Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomas.
Gupta P; Goldenberg DM; Rossi EA; Cardillo TM; Byrd JC; Muthusamy N; Furman RR; Chang CH
Blood; 2012 Apr; 119(16):3767-78. PubMed ID: 22271448
[TBL] [Abstract][Full Text] [Related]
12. A Novel Aziridine-based Bruton's Tyrosine Kinase Inhibitor Induces Apoptosis Through Down-regulation of p65/RelA Phosphorylation on Serine 536 and ERK1/2 in Mantle Cell Lymphoma.
Romanchikova N; Strods A; Strazdina J; Strumfs B; Trapencieris P
Anticancer Res; 2016 Nov; 36(11):6133-6140. PubMed ID: 27793942
[TBL] [Abstract][Full Text] [Related]
13. Rituximab-CD20 complexes are shaved from Z138 mantle cell lymphoma cells in intravenous and subcutaneous SCID mouse models.
Li Y; Williams ME; Cousar JB; Pawluczkowycz AW; Lindorfer MA; Taylor RP
J Immunol; 2007 Sep; 179(6):4263-71. PubMed ID: 17785867
[TBL] [Abstract][Full Text] [Related]
14. Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma.
Vijaya Kumar A; Donate C; Imhof BA; Matthes T
J Vis Exp; 2018 Mar; (133):. PubMed ID: 29658927
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.
Wang Y; Lui WY
Eur J Cancer; 2012 Dec; 48(18):3475-87. PubMed ID: 22647687
[TBL] [Abstract][Full Text] [Related]
16. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.
Weinstein S; Toker IA; Emmanuel R; Ramishetti S; Hazan-Halevy I; Rosenblum D; Goldsmith M; Abraham A; Benjamini O; Bairey O; Raanani P; Nagler A; Lieberman J; Peer D
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E16-22. PubMed ID: 26699502
[TBL] [Abstract][Full Text] [Related]
17. NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines.
Verner J; Trbusek M; Chovancova J; Jaskova Z; Moulis M; Folber F; Halouzka R; Mayer J; Pospisilova S; Doubek M
Leuk Lymphoma; 2015; 56(11):3198-206. PubMed ID: 25827173
[TBL] [Abstract][Full Text] [Related]
18. ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.
Chen Z; Teo AE; McCarty N
Clin Cancer Res; 2016 Jan; 22(1):187-99. PubMed ID: 26350264
[TBL] [Abstract][Full Text] [Related]
19. Junctional adhesion molecule C (JAM-C) dimerization aids cancer cell migration and metastasis.
Garrido-Urbani S; Vonlaufen A; Stalin J; De Grandis M; Ropraz P; Jemelin S; Bardin F; Scheib H; Aurrand-Lions M; Imhof BA
Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):638-649. PubMed ID: 29378216
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
Montraveta A; Xargay-Torrent S; Rosich L; López-Guerra M; Roldán J; Rodríguez V; Lee-Vergés E; de Frías M; Campàs C; Campo E; Roué G; Colomer D
Oncotarget; 2015 Aug; 6(25):21159-72. PubMed ID: 26110568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
